Envista Holdings Corp. (NVST)
22.14
+0.04
(+0.18%)
USD |
NYSE |
Dec 11, 16:00
22.14
0.00 (0.00%)
After-Hours: 20:00
Envista Holdings Research and Development Expense (TTM): 108.60M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| West Pharmaceutical Services, Inc. | 71.00M |
| Align Technology, Inc. | 381.75M |
| Dentsply Sirona, Inc. | 152.00M |
| Abbott Laboratories | 2.897B |
| Masimo Corp. | 172.00M |